Advanced Biomed (ADVB) Beginning Cash Balance (2025)

Advanced Biomed's (ADVB) quarterly Beginning Cash Balance came in at $6715.0 in Q4 2025, down 40.18% quarter-over-quarter from $11226.0 in Q3 2025.

Advanced Biomed (ADVB) Beginning Cash Balance (2025) Analysis & Trends

Advanced Biomed has disclosed Beginning Cash Balance across 1 years of filings, most recently posting $6715.0 for Q4 2025.

Beginning Cash Balance for Q4 2025 came in at $6715.0, changed N/A year-over-year; the trailing twelve-month figure through Dec 2025 was $304309.0 (changed N/A YoY), and the FY2025 annual result was $237552.0, changed N/A from the prior year.
Beginning Cash Balance came in at $6715.0 for Q4 2025 at Advanced Biomed, down from $11226.0 in the prior quarter.
In the past five years, Beginning Cash Balance ranged from a high of $236368.0 in Q2 2025 to a low of $6715.0 in Q4 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Waters	30,529.42 Bn	30,528.96 Bn	1.11 Bn
2	Thermo Fisher Scientific	183.75 Bn	180.50 Bn	7.74 Bn
3	Danaher	133.13 Bn	127.43 Bn	3.59 Bn
4	Idexx Laboratories	46.14 Bn	45.94 Bn	722.74 Mn
5	Agilent Technologies	38.20 Bn	36.39 Bn	990.00 Mn
6	Natera	31.50 Bn	30.40 Bn	696.04 Mn
7	Iqvia Holdings	31.34 Bn	29.36 Bn	1.36 Bn
8	Illumina	24.51 Bn	23.36 Bn	721.00 Mn
9	Mettler Toledo International	23.53 Bn	23.47 Bn	555.82 Mn
10	Advanced Biomed	-	-	-

Download Data